Jeffrey T. L. Smith, EVP & Chief Medical Officer: Zymeworks ZYME Sell · Filed 01/12

Trade details

Type: Insider sale
Amount: $211,057.7
Shares · price: 9,310 sh · $22.67 a share
Held after: 26,708 sh
Stock: Zymeworks ZYME
Person: Jeffrey T. L. SmithEVP & Chief Medical Officer
Trade date: 26/01/12
Filed: 26/01/12
Days to filing: 0 days

Sold 25.8% of holdings

Share of holding sold: 25.8%

Zymeworks trades, last 26 weeks

What else happened in Zymeworks around then

Filed or reported within 30 days of the trade day · 25/12/13~02/11

Jeffrey T. L. Smith's recent trades

Jeffrey T. L. SmithEVP & Chief Medical Officer
Planned saleZymeworks
Planned sale
Zymeworks
ZYME
$6.1M
247,333 sh
$6.1M
Filed 03/06
Traded 03/06
Jeffrey T. L. SmithEVP & Chief Medical Officer
Planned saleZymeworks
Planned sale
Zymeworks
ZYME
$215.7K
9,310 sh
$215.7K
Filed 01/12
Traded 01/12
Jeffrey T. L. SmithEVP & Chief Medical Officer
SellZymeworks
Sell
Zymeworks
ZYME
$264.5K
10,538 sh
$264.5K
Filed 01/05
Traded 01/05
Jeffrey T. L. SmithEVP & Chief Medical Officer
Planned saleZymeworks
Planned sale
Zymeworks
ZYME
$280.5K
10,538 sh
$280.5K
Filed 01/05
Traded 01/05
Jeffrey T. L. SmithEVP & Chief Medical Officer
SellZymeworks
Sell
Zymeworks
ZYME
$165.8K
11,110 sh
$165.8K
Filed 25/01/06
Traded 25/01/06